Patent Assignment
Reel/Frame 040672/0937
Security Interest
Recorded: 2016-12-19
Pages: 6
Assignor
ALKERMES PHARMA IRELAND LIMITED
Executed: 2016-11-03
Assignee
MORGAN STANLEY SENIOR FUNDING, INC.
1585 BROADWAY, NEW YORK, NEW YORK, 10036
Covered Properties
(3)
Naltrexone Long Acting Formulations and Methods of Use
Application:
15/254,580 →
COMPOSITIONS OF BUPRENORPHINE AND µ ANTAGONIST1
Prodrugs of Fumarates and Their Use in Treating Various Diseases
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Dec 4, 2018
From: ALKERMES PHARMA IRELAND LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 047671/0386 →
Assignment of Assignor's Interest
Dec 23, 2019
From: ZEIDAN, TAREK A.; DUNCAN, SCOTT; HENCKEN, CHRISTOPHER P.; WYNN, THOMAS ANDREW
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 051354/0700 →
Security Interest
Mar 20, 2020
From: ALKERMES PHARMA IRELAND LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 052914/0832 →
Security Interest
Oct 23, 2025
From: ALKERMES PHARMA IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 073213/0302 →
Security Interest
Feb 13, 2026
From: ALKERMES PHARMA IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 074858/0405 →
Release of Security Interest in Patents Previously Recorded at Reel/Frame (073213/0302)
Feb 13, 2026
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 074858/0429 →